Although various PHGDH inhibitors have been developed (including ketothioamide, BI-4924, indoleamide, piperazine-1-thiourea inhibitors, and allosteric inhibitors) and have demonstrated anti-tumor effects, no PHGDH inhibitors have been approved by the FDA for clinical application, as a result of challenges such as metabolic compensation, drug selectivity, resistance, toxicity, and the complexity of drug development [165, 166]
Roughly 240,000 of these patients will die as
Interestingly, glucose intolerance could be improved when IGF-1 was systemically administered
REX MD offers remote medical care and a range of products that may retail at a lower price than similar products from a traditional pharmacy